Human p58 natural killer cell receptor precursor mRNA, clone cl-42, co - Nucleotide

Run BLAST
Find regions of similarity between this sequence and other sequences using BLAST.
Pick Primers
Design and test primers for this sequence using Primer-BLAST.

KIR2DL1 gene is a surrogate marker of protection against infection-related hospitalization among HIV-1 unexposed versus exposed uninfected infants in Cameroon. [BMC Immunol. 2024]
KIR2DL1 gene is a surrogate marker of protection against infection-related hospitalization among HIV-1 unexposed versus exposed uninfected infants in Cameroon.
Simeni LK, Ekali GL, Yengo CK, Wouambo RK, Fischer J, Bessong OMA, Fokam J, Yindom LM, Nguedia JCA. BMC Immunol. 2024 Aug 1; 25(1):54. Epub 2024 Aug 1.
Activating KIR/HLA-I combinations as a risk factor of adult B-ALL. [Hum Immunol. 2024]
Activating KIR/HLA-I combinations as a risk factor of adult B-ALL.
Halimi H, Mirzazadeh S, Kalantar K, Hajimaghsoodi M, Ramzi M, Farjadian S. Hum Immunol. 2024 Mar; 85(2):110750. Epub 2024 Jan 23.
KIR2DS1 and KIR2DL1-C245 Dominantly Repress NK Cell Degranulation Triggered by Monoclonal or Bispecific Antibodies, whereas Education by Uptuning Inhibitory Killer Ig-related Receptors Exerts No Advantage in Ab-dependent Cellular Cytotoxicity. [J Immunol. 2024]
KIR2DS1 and KIR2DL1-C245 Dominantly Repress NK Cell Degranulation Triggered by Monoclonal or Bispecific Antibodies, whereas Education by Uptuning Inhibitory Killer Ig-related Receptors Exerts No Advantage in Ab-dependent Cellular Cytotoxicity.
Leijonhufvud C, Sanz-Ortega L, Schlums H, Gaballa A, Andersson A, Eriksson C, Segerberg F, Uhlin M, Bryceson YT, Carlsten M. J Immunol. 2024 Mar 1; 212(5):868-880.